Baysient® develops SaaS, cloud-based software that provides medical providers with a full line of individual dosage-determination products for both small molecule drugs and biologics to facilitate individualized and improved treatment outcomes for inflammatory diseases such as IBD, RA, etc. Baysient’s software uses Bayesian models, routine lab results, and demographic information to allow physicians to individualize dosing to a specific target trough level.